Apollo Hospitals Enterprise Ltd's Q2FY17 standalone net profit rises 2.22% yoy to Rs.92 crore : Beats Estimates

India Infoline Research Team | November 11, 2016 14:49 IST

Apollo Hospitals Enterprise Ltd Q2FY17

Standalone Results Q2FY17: (Rs. in crore)

Q2FY17 YoY (%)
Revenue 1,634 15.9
EDITDA 222 13.3
EBITDA Margin (%) 13.6 [31]
Net Profit (adjusted) 92 2.2
***EBITDA margin change is bps


Apollo Hospitals Enterprise Ltd’s Q2FY17 result beats the market consensus. The street was expecting top-line growth of ~11.6% yoy and bottom-line profit to decline by ~3.3%yoy.

The net revenue for the quarter grew by 15.9% yoy to Rs 1634 cr due to 11.6% growth in healthcare services.

The EBITDA grew by 13.3% to Rs 222 cr against Rs 196 cr of last year. The EBITDA margin declined by 31 bps and stood at 13.6% in Q2FY17 due to higher purchases of stock in trade.

The net profit grew by 2.2% to Rs 92 cr against Rs 90 cr of last year due to higher other income of Rs 9 cr.

Technical View:

Apollo Hospitals Enterprise Ltd is currently trading at Rs. 1266.05, down by 42.3 points or 3.23% from its previous closing of Rs. 1308.35 on the BSE.
The scrip opened at Rs. 1315 and has touched a high and low of Rs. 1315 and Rs. 1261.8 respectively. So far 102210(NSE+BSE) shares were traded on the counter. The stock is currently trading above its 200 DMA.

BSE 1,200.05 [19.55] ([1.60]%)
NSE 1,197.95 [9.25] ([0.77]%)

***Note: This is a NSE Chart

 

Advertisements

  • Get your free IIFL Demat & Trading A/c now...Click here
  • Get IIFL express personal loan disbursal in just 8* hours...Know More
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.